These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 16629895

  • 1. Feasibility of using collagen as the base of the antifungal drug, miconazole.
    Yoshida K, Hirai K, Ara T, Ito M, Wang PL, Igarashi Y.
    J Oral Rehabil; 2006 May; 33(5):363-7. PubMed ID: 16629895
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
    Lamfon H, Porter SR, McCullough M, Pratten J.
    J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
    [Abstract] [Full Text] [Related]

  • 3. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
    Wei GX, Bobek LA.
    J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
    [Abstract] [Full Text] [Related]

  • 4. The action of miconazole of the growth of Candida albicans.
    Van Den Bossche H, Willemsens G, Van Cutsem JM.
    Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
    [Abstract] [Full Text] [Related]

  • 5. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
    Kurnatowski P, Makieło L, Horwatt-Bozyczko E.
    Wiad Parazytol; 2001 Mar; 47(4):867-73. PubMed ID: 16886440
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL, Monroy E, Negrete E, Vaca S.
    Rev Latinoam Microbiol; 2002 Mar; 44(2):65-8. PubMed ID: 17063773
    [Abstract] [Full Text] [Related]

  • 7. Action of miconazole at high concentrations against Candida albicans.
    D'Auria FD, Villa A, Simonetti N.
    J Chemother; 1989 Jul; 1(4 Suppl):240-2. PubMed ID: 16312385
    [No Abstract] [Full Text] [Related]

  • 8. Changes in the cellular composition of Candida albicans resistant to miconazole.
    Sharma S, Khuller GK.
    Indian J Biochem Biophys; 1996 Oct; 33(5):420-4. PubMed ID: 9029825
    [Abstract] [Full Text] [Related]

  • 9. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH, Cheung BP, Parahitiyawa N, Seneviratne CJ, Yau JY, Yeung KW, Samaranayake LP.
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [Abstract] [Full Text] [Related]

  • 10. Tensidols, new potentiators of antifungal miconazole activity, produced by Aspergillus niger FKI-2342.
    Fukuda T, Hasegawa Y, Hagimori K, Yamaguchi Y, Masuma R, Tomoda H, Omura S.
    J Antibiot (Tokyo); 2006 Aug; 59(8):480-5. PubMed ID: 17080684
    [Abstract] [Full Text] [Related]

  • 11. Comparative ability of various prescription and over-the-counter topical antifungal drug products to inhibit the growth of C. albicans.
    Miner N, Armstrong M.
    Adv Wound Care; 1994 Nov; 7(6):53, 55-6. PubMed ID: 7795865
    [Abstract] [Full Text] [Related]

  • 12. Effect of antifungal gels incorporated into a tissue conditioning material on the growth of Candida albicans.
    Radnai M, Whiley R, Friel T, Wright PS.
    Gerodontology; 2010 Dec; 27(4):292-6. PubMed ID: 19732159
    [Abstract] [Full Text] [Related]

  • 13. Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.
    Siikala E, Richardson M, Pfaller MA, Diekema DJ, Messer SA, Perheentupa J, Saxén H, Rautemaa R.
    Int J Antimicrob Agents; 2009 Dec; 34(6):607-9. PubMed ID: 19748230
    [No Abstract] [Full Text] [Related]

  • 14. Citridones, new potentiators of antifungal miconazole activity, produced by Penicillium sp. FKI-1938. I. Taxonomy, fermentation, isolation and biological properties.
    Fukuda T, Yamaguchi Y, Masuma R, Tomoda H, Omura S.
    J Antibiot (Tokyo); 2005 May; 58(5):309-14. PubMed ID: 16060382
    [Abstract] [Full Text] [Related]

  • 15. Antifungal efficiency of miconazole and econazole and the interaction with transport protein: a comparative study.
    Hu Z, Zhang J, Cheng X.
    Pharm Biol; 2015 Feb; 53(2):251-61. PubMed ID: 25376919
    [Abstract] [Full Text] [Related]

  • 16. Microwave assisted one pot synthesis of some novel 2,5-disubstituted 1,3,4-oxadiazoles as antifungal agents.
    Sangshetti JN, Chabukswar AR, Shinde DB.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):444-8. PubMed ID: 21095127
    [Abstract] [Full Text] [Related]

  • 17. Miconazole gel compared with Zataria multiflora Boiss. gel in the treatment of denture stomatitis.
    Amanlou M, Beitollahi JM, Abdollahzadeh S, Tohidast-Ekrad Z.
    Phytother Res; 2006 Nov 01; 20(11):966-9. PubMed ID: 16906641
    [Abstract] [Full Text] [Related]

  • 18. In vitro effectiveness of mouthrinses against Candida albicans.
    Nakamoto K, Tamamoto M, Hamada T.
    Int J Prosthodont; 1995 Nov 01; 8(5):486-9. PubMed ID: 8595107
    [Abstract] [Full Text] [Related]

  • 19. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity.
    Aljaeid BM, Hosny KM.
    Int J Nanomedicine; 2016 Nov 01; 11():441-7. PubMed ID: 26869787
    [Abstract] [Full Text] [Related]

  • 20. Anticandidal activity and biocompatibility of a rechargeable antifungal denture material.
    Villar CC, Lin AL, Cao Z, Zhao XR, Wu LA, Chen S, Sun Y, Yeh CK.
    Oral Dis; 2013 Apr 01; 19(3):287-95. PubMed ID: 22957799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.